A Phase I Study of Ipilimumab in Children, Adolescents, and Young Adults with Treatment-Refractory Cancer
[Protocol 10-193] |
Wexler, Leonard, MD |
A Phase I/IB Study of IMC-20D7S in Patients with Progressive Malignant Melanoma
[Protocol 10-069] |
Wolchok, Jedd, MD, PhD |
A Phase I/II Study of CDX-1401 in Patients with Cancers Known to Express NY-ESO-1
[Protocol 09-165] |
Keohan, Mary, MD |
A Phase Ib Study of MDX-1106 (BMS-936558) in Combination with Ipilimumab (BMS-734016) in Patients with Unresectable Stage III or Stage IV Malignant Melanoma
[Protocol 09-155] |
Wolchok, Jedd, MD, PhD |
A Phase Ib Study of MDX-1106 in Patients with Selected Advanced or Recurrent Malignancies
[Protocol 09-012] |
Carvajal, Richard, MD |
A Phase IB/II Study of RO4929097 plus Cisplatin, Vinblastine, and Temozolomide in Patients with Metastatic Melanoma
[Protocol 10-085] |
Dickson, Mark, MD |
A Phase II Study of Nilotinib (AMN107) in Patients with Metastatic Mucosal, Acral, or Chronically Sun-Damaged Melanoma
[Protocol 09-055] |
Carvajal, Richard, MD |
A Phase II Study of RAD001 (Everolimus) and Pasireotide (SOM230)) in Patients with Advanced Uveal Melanoma
[Protocol 10-123] |
Carvajal, Richard, MD |
A Phase III Study of Nilotinib (Tasigna?) versus Dacarbazine in Patients with Advanced Melanoma with a c-Kit Mutation (TEAM Trial
[Protocol 10-102] |
Carvajal, Richard, MD |
A Phase III Study of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy in Patients with Cutaneous Melanomas that Have Metastasized to the Sentinel Node
[Protocol 09-112] |
Ariyan, Charlotte, MD |
A Study of MORAb-004 Monotherapy in Patients with Metastatic Melanoma
[Protocol 11-088] |
D'Angelo, Sandra, MD |
Phase II Study of Ipilimumab Plus Isolated Limb Infusion with Melphalan and Dactinomycin to Treat Advanced Unresectable Melanoma of the Extremity
[Protocol 10-101] |
Ariyan, Charlotte, MD |
Phase II Trial of Temozolomide versus AZD6244 in Patients with Metastatic Uveal Melanoma
[Protocol 10-053] |
Carvajal, Richard, MD |
